Publication | Closed Access

Toll-Like Receptor 2 Antagonist Ameliorates Type 2 Diabetes Mellitus Associated Neuropathic Pain by Repolarizing Pro-inflammatory Macrophages

InflammationToll-like ReceptorsAnti-inflammatoryAutoimmune DiseasePain MedicineDiabetesImmunologyPharmacologyChronic InflammationNeuropathic PainMolecular PainMedicinePro-inflammatory MacrophagesToll-like Receptor 2Pain Research